Loading...
•
Dec 31, 2021
Azenta Q1 2022 Earnings Report
Reported continued double-digit growth and a strong balance sheet.
Key Takeaways
Azenta reported a strong start to fiscal year 2022, with revenue from continuing operations reaching $140 million, an 18% increase year-over-year, driven by robust demand for product and service offerings.
Revenue from continuing operations was $140 million, up 18% year over year.
Life Sciences Products revenue grew 10% year over year, driven by strength in automated ultra-cold storage systems.
Life Sciences Services revenue was up 24% year over year, with growth in both Sample Repository Solutions and Genomic Services.
Diluted EPS from continuing operations was $0.04 per share.
Forward Guidance
The Company announced revenue and earnings guidance for continuing operations for the second quarter of fiscal 2022. Revenue is expected to be in the range of $137 million to $147 million and non-GAAP diluted earnings per share for the second fiscal quarter is expected to be in the range of $0.07 to $0.15. GAAP diluted earnings per share from continuing operations is expected to be in the range of ($0.04) to $0.04.
Positive Outlook
- Revenue is expected to be in the range of $137 million to $147 million
- Non-GAAP diluted earnings per share for the second fiscal quarter is expected to be in the range of $0.07 to $0.15.
Challenges Ahead
- GAAP diluted earnings per share from continuing operations is expected to be in the range of ($0.04) to $0.04.
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...